GlassScriptPhysician profile
Amy M Olex
NPI 1528038221
$855.05
in general payments reported to CMS, 2019-2025
11 companies · $280 in 2025
The $280 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44.05 · 2020: $17.20 · 2023: $167 · 2024: $347 · 2025: $280.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $794.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $793.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $200.90 | 2024-2025 | Eylea Hd |
| Tarsus Pharmaceuticals, INC. | $163.37 | 2024-2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $140.58 | 2023-2024 | Cequa |
| Alcon Vision LLC | $71.26 | 2019-2025 | Clareon, Precision 1 |
| Genentech USA, INC. | $61.56 | 2023-2025 | Vabysmo |
| Astellas Pharma US INC | $58.90 | 2024 | Izervay |
| Bausch & Lomb Americas INC. | $56.02 | 2024 | Vyzulta, Infuse, Biotrue |
| Abbvie INC. | $41.94 | 2024-2025 | |
| Allergan, INC. | $25.33 | 2019 | |
| Alimera Sciences, INC. | $17.99 | 2024 | Iluvien, Yutiq |
| Carl Zeiss Meditec Ag | $17.20 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Olex listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.